End-stage, age-related macular degeneration (AMD) is the leading cause of irreversible vision loss and legal blindness in people over 65. A new FDA-approved, implantable miniature telescopic lens is now available through a treatment program that has partnered with Blind & Vision Rehabilitation Services of Pittsburgh, Dr. Viki Christopoulos and Dr. Pamela Rath.
This comprehensive treatment program has been designed by CentraSight, the only treatment program available in the United States that uses an FDA-approved implantable telescopic lens. This multidisciplinary team will be led by a retina specialist and will provide patient candidacy assessment, visual training and rehabilitation.
The treatment program involves four steps:
- Diagnosis of end-stage AMD by a retina physician
- Presurgery training by low vision specialists at
Blind & Vision Rehab
- Implantation surgery by Dr. Viki Christopoulos
- Rehabilitation at Blind & Vision Rehab.
If you are interested in finding out if you are a candidate for the telescope implant, please call Dr. Erica Hacker at 412-368-4400 ext. 2231.
Additional details are available at www.centrasight.com.
You may also submit the candidacy questionnaire that follows.